The Role of the Health Care Professional in Ensuring the Safe and Effective Use of Dietary Supplements
FacultyMary M. Bridgeman, PharmD, BCPS, CGP
Internal Medicine Clinical Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey
Clinical Associate Professor
Ernest Mario School of Pharmacy
Rutgers, the State University of New Jersey
Piscataway, New Jersey
Editorial SupportYvette C. Terrie, RPh
Educational Objectives:At the completion of this activity, the participant will be able to:
- Examine common nutritional deficiencies in the United States.
- Identify appropriate candidates for dietary supplementation.
- Explore the role of the health care professional in educating patients on the appropriate use of dietary supplements and the potential for drug interactions.
Statement of NeedDietary and herbal supplements are used by approximately 50% and 20% of adults in the United States, respectively. Health care practitioners should be knowledgeable about common nutritional deficiencies so that they ensure that patients are appropriately using these supplements. According to an ongoing survey by the CDC, the most common nutritional deficiencies include iron, vitamin D, calcium, vitamin B6, and vitamin C. Health care professionals, including nurse practitioners, physician assistants, and pharmacists are key individuals who can educate patients on the safe and effective use of these products. They can identify patients at risk for nutritional deficiencies, counsel on potential drug-drug interactions with these supplements, and provide education on these products as needed.
Table of Contents DescriptionHealth care professionals play a significant role in identifying patients who are at risk for nutritional deficiencies or who have increased metabolic demands and educating them on the utilization of various dietary supplements.
Target Audience: This activity is intended for advanced practice nurses, nurse practitioners, and physician assistants working in convenient care clinics.
Release date: June 12, 2016
Expiration date: June 12, 2018
This activity is jointly provided by Dannemiller and Pharmacy Times Continuing Education.
Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Dannemiller and Pharmacy Times Continuing Education. Dannemiller is accredited by ACCME to provide continuing medical education for physicians.
Dannemiller designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)TM from organizations accredited by ACCME.
Dannemiller is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 090419.
This program is accredited for 1.0 contact hour(s) which includes 1.0 hours of pharmacology.
Method of ParticipationTo receive credit, all participants will need to read the objectives and other introductory CME/CE information, take the pretest, and then proceed to the educational activity. Once the activity is completed along with the posttest and the evaluation, participants can request credit.
You will have access to your certificate immediately following completion of the evaluation. Credit is provided until 6/12/2017. No credit will be given after this date. There is no fee to participate in this activity.
In the event you have questions about this activity or are unable to retrieve the certificate, please e-mail email@example.com and a certificate will be emailed within 2 weeks.
System Requirements for Completion of Posttest and EvaluationComputer or smart phone with Internet access
DisclosuresIn accordance with the Accreditation Council for Continuing Medical Education (ACCME), Dannemiller requires that any person who is in a position to control the content of a CME/CE activity must disclose all financial relationships they have with a commercial interest.
The following contributor(s) have no relevant financial relationships with commercial interests to disclose:
Mary M. Bridgeman, PharmD, BCPS, CGP
Yvette C. Terrie, RPh
Pharmacy Times Continuing Education
Planning Staff—David Heckard; Maryjo Dixon, RPh; Dipti Desai, PharmD, RPh; Donna Fausak; and Tara DeLorenzo
Pharmacy Times Editorial Staff—Katie Eder
Dannemiller—Gordon Ringler and Jennifer Hodge
An anonymous peer reviewer was part of the content validation and conflict resolution and has no relevant financial relationships with commercial interests to disclose.
Off-label StatementThis educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
DisclaimerThe content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller or Pharmacy Times Continuing Education. This material is prepared based on a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials on the subject.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.